14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase
Journal of Cell Science · 2025
DOI: 10.1242/jcs.263808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Monika A Jaiswal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Tumour Biology , Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar Node, Navi Mumbai 4…. Hauptthemen laut MEDLINE: 14-3-3 Proteins, Centrioles, Cell Cycle Proteins, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Government of India, Department of Atomic Energy, Government of India, Advanced Centre for Treatment, Research and Education in Cancer.
Abstract (Originalsprache)
The 14-3-3 protein family regulates several pathways in mammalian cells, including centrosome duplication. However, the precise mechanisms by which 14-3-3 paralogs regulate the centrosome cycle remain unclear. To identify the mechanisms by which 14-3-3ε regulates centrosome duplication, we altered two conserved acidic residues in the 14-3-3ε phospho-peptide-binding pocket that regulate complex formation and dissociation with the associated ligands, D127 and E134, to alanine. Altering these residues to alanine led to opposing effects on centrosome duplication; the D127A mutant inhibited centrosome duplication, whereas cells expressing the E134A mutant showed the presence of supernumerary centrosomes. We demonstrate that 14-3-3ε does not inhibit centriole duplication, as reported for 14-3-3γ, but inhibits centriole disengagement. Using a combination of pharmacological and genetic approaches, we demonstrate that 14-3-3ε inhibits the activity of Plk1 and separase [also known as separin (ESPL1)], leading to disengagement defects that ultimately lead to decreased proliferation and cell death. Our work demonstrates that different 14-3-3 paralogs regulate different steps in the centrosome cycle and that disrupting complex formation between 14-3-3ε and Plk1 or separase could be a novel therapeutic strategy in tumor cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell and Tumour Biology , Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar Node, Navi Mumbai 410210, India.
- Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai 400085, India.
ORCID-Profile: Monika A Jaiswal, Akshay Karn, Aparna Das, Anisha Kumari, Shilu Tiwari, Sorab N Dalal
Förderung
- Department of Biotechnology, Government of India
- Department of Atomic Energy, Government of India
- Advanced Centre for Treatment, Research and Education in Cancer
- Department of Biotechnology
- Department of Atomic Energy
- Advanced Centre for Treatment Research and Education in Cancer
- Tata Memorial Centre, ACTREC
Zitieren
APA
Jaiswal, M. A., Karn, A., Das, A., Kumari, A., Tiwari, S., & Dalal, S. N. (2025). 14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase. Journal of Cell Science. https://doi.org/10.1242/jcs.263808
Vancouver
Jaiswal MA, Karn A, Das A, Kumari A, Tiwari S, Dalal SN. 14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase. Journal of Cell Science. 2025. doi:10.1242/jcs.263808
BibTeX
@article{Jaiswal2025,
author = {Jaiswal, Monika A and Karn, Akshay and Das, Aparna and Kumari, Anisha and Tiwari, Shilu and Dalal, Sorab N},
title = {14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase},
journal = {Journal of Cell Science},
year = {2025},
doi = {10.1242/jcs.263808}
}
EUVIMED